Ironwood Pharmaceuticals Announces FDA Orphan Drug Designation for Olinciguat for the Treatment of Sickle Cell Disease Biotech Investing
Aduro Biotech Announces Initiation of Phase 1b Clinical Trial in Non-Small Cell Lung Cancer under Janssen Strategic Partnership Biotech Investing
Cellectar Granted U.S. Patent for the Treatment of Various Cancers and Cancer Stem Cells with CLR 131 Pharmaceutical Investing
Chimerix Receives Orphan Drug Designation from the FDA for Brincidofovir for the Treatment of Smallpox Pharmaceutical Investing
FibroGen Announces Completion of Enrollment in U.S. Phase 3 Clinical Program for Roxadustat Pharmaceutical Investing
RISE Life Science Corp. to Acquire California CBD Company Life Bloom Organics and Leading Cannabis Brand Strategy Agency Cultivate Kind Cannabis Investing News
Q BioMed Inc. Provides Important Update on Mannin Research Tie2 Technology Platform Development Biotech Investing
